Patents by Inventor Luitgard Seedorf

Luitgard Seedorf has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070281988
    Abstract: The present invention relates to a method of treating one or more vascular complications of hyperglycemia comprising administering to a patient in need of treatment for one or more vascular complications to hyperglycemia a therapeutically effective amount of ruboxistaurin, or a pharmaceutically acceptable salt thereof in combination with a therapeutically effective amount of an HMG-CoA reductase inhibitor.
    Type: Application
    Filed: December 16, 2005
    Publication date: December 6, 2007
    Inventors: Norman Cameron, Hans-Jurgen Mest, Klaus Seedorf, Luitgard Seedorf
  • Patent number: 5719022
    Abstract: To diagnose non-insulin dependent diabetes mellitus or a genetically conditioned disposition thereto, examinations are made of tissue cells, especially skeletal muscle cells, from the person concerned for the presence of the human insulin receptor type B (HIR-B). This examination is preferably conducted with the aid of specific oligonucleotides as primers in a PCR amplification reaction of cDNA obtained from tissue RNA which enables a distinction to be made between HIR-A and HIR-B RNA.
    Type: Grant
    Filed: November 21, 1994
    Date of Patent: February 17, 1998
    Assignee: Max-Planck-Gesellschaft zur Forderung der Wissenschaften E.V.
    Inventors: Luitgard Seedorf, Hans-U. Haring, Axel Ullrich